Zhejiang Tianyu Pharmaceutical Co., Ltd. Announcement on Wholly-Owned Subsidiary's Drug Approval
The Board of Directors and all directors of the Company guarantee that the announcement content is free from false representations, misleading statements, or material omissions, and that they will bear individual and joint legal responsibility for the authenticity, accuracy, and completeness of the content.
Zhejiang Tianyu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company")'s wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd. (hereinafter referred to as "Nuode Pharmaceutical"), recently received the "Drug Registration Certificate" for Apalutamide Tablets, approved and issued by the National Medical Products Administration (hereinafter referred to as the "NMPA"). The relevant situation is hereby announced as follows:
I. Drug Information
- Basic Drug Information